Produkty 83808-48-4

CAS 83808-48-4 występuje w naszej ofercie pod nazwami: 5alpha-Androstane-2beta,3alpha-diol-17-one, 2beta,3alpha-Dihydroxy-5alpha-androst-17-one, (2beta,3alpha,5alpha)-2,3-Dihydroxyandrostan-17-one, Concentration: 100 µg/ml Solvent: Acetonitrile. Oferty producentów: TRC, HPC Standards. Dostępne opakowania: 50mg, 1x5mg, 1x1ml.

5alpha-Androstane-2beta,3alpha-diol-17-one
TRC
  • opakowanie: 50mg
  • Warianty: 1
Zobacz produkt
2beta,3alpha-Dihydroxy-5alpha-androst-17-one
HPC Standards
  • opakowanie: 1x5mg
  • Warianty: 1
Zobacz produkt
(2beta,3alpha,5alpha)-2,3-Dihydroxyandrostan-17-one, Concentration: 100 µg/ml Solvent: Acetonitrile
HPC Standards
  • opakowanie: 1x1ml
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,3S,5S,8R,9S,10S,13S,14S)-2,3-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one (CAS 83808-48-4) to związek chemiczny o wzorze sumarycznym C19H30O3 i masie molowej 306.4 g/mol. Nazwa systematyczna IUPAC: (2S,3S,5S,8R,9S,10S,13S,14S)-2,3-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one. InChIKey: HILNXGBHRIVSOD-PPMYXAGCSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H30O3
Masa molowa306.4 g/mol
Nazwa IUPAC(2S,3S,5S,8R,9S,10S,13S,14S)-2,3-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
InChIKeyHILNXGBHRIVSOD-PPMYXAGCSA-N
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 5alpha-Androstane-2beta,3alpha-diol-17-one, 5?-Androstane-2?,3?-diol-17-one
Izomery (ten sam wzór sumaryczny)
dodecyl 2-hydroxybenzoate C19H30O3
dodecyl 4-hydroxybenzoate C19H30O3
ethyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate C19H30O3
(3R,5S,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(1S,3aS,3bR,5aR,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(4R,6R)-6-[2-[(1S,2S,4aR,6R,8aS)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethyl]-4-hydroxyoxan-2-one C19H30O3
(1S,3aS,3bR,5aS,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(3S,4S,5R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one C19H30O3
(4aS,4bR,6aR,10aS,10bS,12aS)-8-hydroxy-10a,12a-dimethyl-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydronaphtho[2,1-f]chromen-2-one C19H30O3
(3R,5R,8R,9S,10S,13S,14S,16R)-3,16-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(3R,5R,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3